Walgreens Boots Alliance Q3 Earnings Beat Expectations As Vaccinations Boost Prescriptions Business


27% profit every 20 days?

This is what Nic Chahine averages with his option buys. Not selling covered calls or spreads… BUYING options. Most traders don’t even have a winning percentage of 27% buying options. He has an 83% win rate. Here’s how he does it.


  • Walgreens Boots Alliance Inc (NASDAQ: WBAreported Q3 earnings of $1.38, beating the consensus estimate of $1.17. Revenue increased 12.1% Y/Y to $34.0 billion, slightly ahead of the consensus of $33.76 billion.
  • Sales and profit strengthened as the vaccination campaign helped ease pandemic conditions for its stores' pharmacy and retail businesses.
  • It has now given more than 25 million vaccinations via walk-in appointments, employer partnerships, and mobile clinics.
  • Sales were up 10.4% on a constant currency basis, reflecting strong growth in the International segment.
  • The United States segment sales of $28.7 billion increased 5.1% Y/Y. Comparable sales increased 6.4%, reflecting an 8.4% and 1.7% increase in comparable pharmacy and retail sales, respectively.
  • The International segment sales witnessed an increase of 75.8% to $5.3 billion, including a favorable currency impact of 17.1%. Sales increased 58.7% on a constant currency basis,
  • Adjusted operating income increased 82.9% on a reported currency basis to $1.5 billion, buoyed by strong adjusted gross profit growth across both pharmacy and retail in the U.S. and a rebound in International segment sales.
  • Adjusted net earnings from continuing operations almost doubled to $1.2 billion.
  • Adjusted gross margin expanded to 21.2% from 19.9% a year ago.
  • Outlook: WBA raised FY21 guidance from mid-to-high single-digit growth to around 10% growth in constant currency-adjusted EPS from continuing operations.
  • The company completed the divestiture of the Alliance Healthcare businesses to AmerisourceBergen for $6.5 billion in cash and stock.
  • A portion of the divestiture proceeds was used to eliminate $3.3 billion in debt. The remaining will be used to accelerate the growth of its core retail pharmacy and healthcare businesses.
  • Price Action: WBA shares are down 7% at $48.92 during the market session on the last check Thursday.
  • Photo by Anthony92931 via Wikimedia

27% profit every 20 days?

This is what Nic Chahine averages with his option buys. Not selling covered calls or spreads… BUYING options. Most traders don’t even have a winning percentage of 27% buying options. He has an 83% win rate. Here’s how he does it.


ENTER TO WIN $500 IN STOCK OR CRYPTO

Enter your email and you'll also get Benzinga's ultimate morning update AND a free $30 gift card and more!

Posted In: EarningsNewsGuidanceHealth CareGeneralBriefs